PSMalpha3 TFA is an inhibitor of NF-kappaB p65 and p38 MAPK. PSMalpha3 TFA forms membrane pores and binds to residues of human insulin B chain to inhibit insulin aggregation. PSMalpha3 TFA forms alpha-type amyloid-like fibrils to exert cytotoxic effects, and acts as a functional amyloid virulence determinant of Staphylococcus aureus. PSMalpha3 TFA is applicable to research related to spondyloarthritis, rheumatoid arthritis, insulin-derived amyloidosis, and Staphylococcus aureus infection[1][2][3].
Molekulargewicht:
2749.15
Formel:
C130H193F3N28O32S
Target-Kategorie:
NF-kappaB,p38 MAPK
Anwendungsbeschreibung:
MCE Product type: Peptides
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
